A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy

Journal of Neurology

Volumn 243, Issue 3, 1996, Pages 280-285

  Thompson, N ^a   Choudhary, P ^a   Hughes, R A C ^a   Quinlivan, R M ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Chronic inflammatory demyelinating polyradiculoneuropathy; Intravenous immunoglobulin

Indexed keywords

IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEMYELINATING DISEASE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEASUREMENT; METHODOLOGY; MOTOR PERFORMANCE; PRIORITY JOURNAL; RADICULOPATHY; RANDOMIZED CONTROLLED TRIAL; WALKING;

ADULT; AGED; CHRONIC DISEASE; CROSS-OVER STUDIES; DEMYELINATING DISEASES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; POLYRADICULONEUROPATHY; PROSPECTIVE STUDIES;

EID: 0030053681     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00868527     Document Type: Article

References (33)

1. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force (1991) Research criteria for the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Neurology 41:617-618
2. Bohannon RW (1986) Test-retest reliability of hand-held dynamometry during a single session of strength assessment. Phys Ther 66:206-209
3. Bohannon RW (1989) Correlation of lower limb strengths and other variables with standing performance in stroke patients. Physiother Can 41: 198-202
4. Cornblath DR, Chaudhry V, Griffin JW (1991) Treatment of chronic inflammatory demyelinating polyradiculoneuropathy with intravenous immunoglobulin. Ann Neurol 30: 104-106
5. Dyck PJ, O'Brien PC, Oviatt KF, Dinapoli RP, Daube JR, Bartleson JD, Mokri B, Swift T, Low PA, Windebank AJ (1982) Prednisolone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 11:136-141
6. Dyck PJ, Daube J, O'Brien P, Pineda A, Low PA, Windebank AJ, Swanson C (1986) Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med 314: 461-465
7. Dyck PJ, Litchy WJ, Kratz KM, Suarez GA, Low PA, Pineda AA, Windebank AJ, Karnes JL, O'Brien PC (1994) A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 36:838-845
8. Faed JM, Day B, Pollock M, Taylor PK, Nukada H, Hammond-Tooke GD (1989) High-dose intravenous human immunoglobulin in chronic inflammatory demyelinating polyneuropathy. Neurology 39:422-425
9. Fisher NM, Pendergast DR, Calkins EC (1990) Maximal isometric torque of knee extension as a function of muscle length in subjects of advancing age. Arch Phys Med Rehabil 71:729-734
10. Goodkin DE, Herstgaard D, Seminary J (1988) Upper extremity function in multiple sclerosis: improving assessment sensitivity with box and nine-hole peg test. Arch Phys Med Rehabil 69:850-854
11. Hahn AF, Bolton CF, Vandervoort P, Feasby TE, Zochodne D (1994) Intravenous immunoglobulin treatment in chronic demyelinating polyneuropathy (CIDP): a double blind placebo-controlled cross-over study. Proceedings of the Peripheral Nerve Study Group Meeting, St. Paul's, Minneapolis, USA. Peripheral Nerve Study Group, Rochester, Minn
12. Hartung HP, Stoll G, Toyka KV (1993) Immune reactions in the peripheral nervous system. In: Dyck PJ, Thomas PK (eds) Peripheral neuropathy. Saunders, Philadelphia, pp 418-444
13. Hauser SL, Dawson DM, Lehrich JR, Beal FM, Kevy SU, Proper RD, Mills JA, Weiner HL (1983) Intensive immunosuppression in progressive multiple sclerosis: a randomised three arm study of high dose intravenous cyclophosphomide, plasma exchange and ACTH. N Engl J Med 308: 173-180
14. Hodgkinson SJ, Pollard JD, McLeod JG (1990) Cyclosporin A in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 53:327-330
15. Hughes RAC (1990) Chronic idiopathic demyelinating polyradiculoneuropathy. In: Guillain-Barré syndrome. Springer, Berlin Heidelberg New York, pp 205-246
16. Iddings DM, Smith KL, Spencer WA (1961) Muscle testing, part 2. Reliability in clinical use. Phys Ther 41:249-256
17. Kaveri SV, Mouthon L, Kazatchkine MD (1994) Immunomodulating effects of intravenous imunoglobulin in autoimmune and inflammatory diseases. J Neurol Neurosurg Psychiatry 57:S6-8
18. Kleyweg RP, Meché FGA van der, Schmitz PIM (1991) Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 14: 1103-1109
19. Lennon SM, Ashburn A (1993) Use of myometry in the assessment of neuropathic weakness: testing for reliability in clinical practice. Clin Rehabil 7: 125-133
20. Lewis RA, Sumner AJ, Brown MJ, Astbury MK (1982) Multifocal demyelinating neuropathy with persistent conduction block. Neurology 32: 1127-1132
21. Lilienfield AM, Jacobs M, Willis M (1954) A study of the reproducibility of muscle testing and certain other aspects of muscle scoring. Phys Ther Rev 34:279-289
22. Medical Research Council (1943) Aids to investigation of peripheral nerve injuries. War memorandum, revised 2nd edn. HMSO, London
23. Oh SJ, Joy JL, Kurnoglu R (1992) "Chronic sensory demyelinating neuropathy": chronic demyelinating polyradiculaoneuropathy presenting as a pure sensory neuropathy. J Neurol Neurosurg Psychiatry 55:677-680
24. Parry GJ, Clarke S (1988) Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle Nerve 11:103-107
25. Pentland B, Adams GGW, Mawdsley G (1982) Chronic idiopathic polyneuropathy treated with azathioprine. J Neurol Neurosurg Psychiatry 45: 866-869
26. Rankin J (1957) Cerebral vascular accidents in patients over the age of 60. 2. Prognosis. Scott Med J 2:200-215
27. Scott OM, Hyde SA, Goddard C, Dubowitz V (1982) Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy. Muscle Nerve 5:291-301
28. Stuberg WA, Metcalf WK (1988) Reliability of quantitative muscle testing in healthy children and in children with Duchenne muscular dystrophy using a hand-held dynamometer. Phys Ther 68: 977-982
29. Van der Ploeg RJO, Oosterhuis HJGH, Reuvekamp J (1984) Measuring muscle strength. J Neurol 231:200-203
30. Van Doom PA, Vermeulen M, Brand A, Mulder PGH, Busch HFM (1991) Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: clinical and laboratory characteristics associated with improvement. Arch Neurol 48:217-220
31. Van Doorn PA, Brand A, Strengers PFW, Meulstee J, Vermeulen M (1990) High dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study. Neurology 40: 209-212
32. Vermeulen M, Doorn PA van, Brand A, Strengers PFW, Jennekens FGI, Busch HFM (1993) Intravenous immunoglobulin with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 56: 36-39
33. Wiles CM, Karni Y, Nicklin J (1990) Laboratory testing of muscle function in the management of neuromuscular disease. J Neurol Neurosurg Psychiatry 53:384-387